All the new drugs ap­proved in 2023: Alzheimer's and gene ther­a­py cap a five-year high

Af­ter kick­ing off 2023 with a po­ten­tial megablock­buster in Ei­sai and Bio­gen’s new Alzheimer’s drug Leqem­bi, in to­tal­i­ty the FDA signed off on 10 more …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.